Real world experience with the Medtronic Reveal monitor

From an abstract presented at the AHA 2016 sessions:

Results: A total of 233 patients were included in the study..The indications for implantation were syncope (37.3%), palpitations (24%), AF management (18%), near syncope (5.2%), cryptogenic stroke (3.9%), bradycardia (3.9%), NSVT (1.7%) and long QT (1.3%). A total of 89 (39%) had a diagnosis made during the follow-up time 8 ±4 months..Diagnoses made were AF 22(24.7%), SVT 17(19%), Sick sinus syndrome 10(11%), symptomatic bradycardia 2 (2%), advanced heart block 4 (4.4%), PVC 4 (4.4%), VT 1(1%), other 29 (32.5%). These diagnoses led to change in medication 19 (21%), office visits 17 (19%), radiofrequency ablation 23 (26%), pacemaker implantation 18 (20%), ICD implantation 4 (4%), and miscellaneous 9 (10%). 24 patients underwent device explantation. A total of 3440 CareLink transmissions occurred during the follow up (mean of 15 transmissions per patient).